Genomic Expression is Diagnostic Equipment in United States that focus on infectious diseases business. Founded in 2009. They cover business area such as developer, commercial-stage RNA Platform, cure, cancer, infectious disease, one disease, one marker, one drug, one patient, many marker, multiple treatment option, validation, life, most patient, FFPE, blood, saliva, doctor, medical practitioner, mrna vaccine, sophisticated combinatorial clinical study.
2009
( 15 years old in 2024 )
Infectious Diseases
-
100 Cummings Center
Suite 451C
Beverly, MA 01915
United States
Private
developercommercial-stage RNA Platformcurecancerinfectious diseaseone diseaseone markerone drugone patientmany markermultiple treatment optionvalidationlifemost patientFFPEbloodsalivadoctormedical practitionermrna vaccinesophisticated combinatorial clinical study
* We use standard office opening hours in near Genomic Expression's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Genomic Expression is Diagnostic Equipment business from United States that founded in 2009 (15 years old in 2024), Genomic Expression business is focusing on Infectious Diseases.
Genomic Expression headquarter office and corporate office address is located in 100 Cummings Center Suite 451C Beverly, MA 01915 United States.
Genomic Expression was founded in United States.
In 2024, Genomic Expression is currently focus on infectious diseases sector.
Above is snippet of Google Trends for "infectious diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Genomic Expression, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.